亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

天津市魯鑫化工科技有限公司  

醫藥中間體,化學試劑,化工原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李傳波
  • 電話:18302279210
  • 郵件:2033859926@qq.com
  • 傳真:022-27905778
  • QQ:2650228284
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 普羅布考 CAS NO.: 23288-49-5
普羅布考 CAS NO.: 23288-49-5
單價 面議對比
詢價 暫無
發貨 天津付款后3天內
庫存 100kg起訂1kg
過期 長期有效
更新 2015-07-04 10:06
 
詳細信息
       化學名稱:4,4'-[(1-甲基亞乙基)二硫]雙[(2,6-二(1.1-二甲乙基)苯酚]

英文名稱:Probucol

分子式:C31H48O2S2

分子量: 517.86

CAS NO.: 23288-49-5

性狀:本品為白色或類白色結晶性粉末,有特臭。本品在****中極易溶解,在乙醇中溶解,在水中不溶。

包裝:20kg/桶

貯藏:遮光密封保存

適用范圍; 降血脂藥。用于高膽固醇血癥。

0%; Ztf_de體;color:black;CAS NO.: 150399-23-8

 

性狀:本品為白色或類白色結晶性粉末,無臭,有引濕性。本品在水中易溶,在甲醇中略溶,在氯仿中幾乎不溶。

包裝:1kg/桶,3kg/桶

貯藏:遮光密封在2-8℃保存

適用范圍; 抗腫瘤藥。用于與順鉑聯合治療無法手術的惡性胸膜間皮瘤。

©2025 天津市魯鑫化工科技有限公司 版權所有   技術支持:化工網   訪問量:9027  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |